Northern Trust Corp Rubius Therapeutics, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.14 - $0.31 $17 - $39	-127 Reduced 0.18%	71,366 $12,000
Q2 2022 Aug 12, 2022	SELL	$0.79 - $5.98 $269,415 - $2.04 Million	-341,032 Reduced 82.67%	71,493 $61,000
Q1 2022 May 13, 2022	SELL	$4.25 - $10.4 $98,396 - $240,780	-23,152 Reduced 5.31%	412,525 $2.27 Million
Q4 2021 Feb 08, 2022	SELL	$9.68 - $17.74 $123,729 - $226,752	-12,782 Reduced 2.85%	435,677 $4.22 Million
Q3 2021 Nov 15, 2021	SELL	$17.6 - $25.91 $464,323 - $683,557	-26,382 Reduced 5.56%	448,459 $8.02 Million
Q2 2021 Aug 13, 2021	BUY	$22.26 - $28.43 $1.72 Million - $2.2 Million	77,428 Added 19.48%	474,841 $11.6 Million
Q1 2021 May 12, 2021	SELL	$8.02 - $32.01 $101,140 - $403,678	-12,611 Reduced 3.08%	397,413 $10.5 Million
Q4 2020 Feb 11, 2021	SELL	$4.23 - $8.73 $45,887 - $94,703	-10,848 Reduced 2.58%	410,024 $3.11 Million
Q3 2020 Nov 16, 2020	SELL	$4.65 - $6.25 $81,723 - $109,843	-17,575 Reduced 4.01%	420,872 $2.11 Million
Q2 2020 Aug 14, 2020	SELL	$4.01 - $6.88 $59,612 - $102,278	-14,866 Reduced 3.28%	438,447 $2.62 Million
Q1 2020 May 14, 2020	BUY	$3.74 - $9.84 $24,927 - $65,583	6,665 Added 1.49%	453,313 $2.02 Million
Q4 2019 Feb 14, 2020	SELL	$7.23 - $14.12 $5,675 - $11,084	-785 Reduced 0.18%	446,648 $4.24 Million
Q3 2019 Nov 13, 2019	BUY	$7.85 - $15.75 $530,000 - $1.06 Million	67,516 Added 17.77%	447,433 $3.51 Million
Q2 2019 Aug 13, 2019	BUY	$13.5 - $19.94 $172,165 - $254,294	12,753 Added 3.47%	379,917 $5.98 Million
Q1 2019 May 13, 2019	BUY	$13.27 - $18.51 $2.6 Million - $3.63 Million	195,919 Added 114.41%	367,164 $6.65 Million
Q4 2018 Feb 12, 2019	BUY	$13.83 - $22.97 $507,201 - $842,401	36,674 Added 27.25%	171,245 $2.75 Million
Q3 2018 Nov 14, 2018	BUY	$20.06 - $26.94 $2.7 Million - $3.63 Million	134,571 New	134,571 $3.23 Million

Others Institutions Holding RUBY

# of Institutions

Shares Held

325

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

325
Shares

$0
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Rubius Therapeutics, Inc.

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

More about RUBY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account